Next Article in Journal
Genome-Wide Association between the 2q33.1 Locus and Intracranial Aneurysm Susceptibility: An Updated Meta-Analysis Including 18,019 Individuals
Previous Article in Journal
Pretransplant Cardiac Evaluation Using Novel Technology
Article Menu

Export Article

Open AccessArticle

Phosphoproteins Involved in the Inhibition of Apoptosis and in Cell Survival in the Leiomyoma

1
Institute for Maternal and Child Health–IRCCS “Burlo Garofolo”, 65/1 Via dell’Istria, I-34137 Trieste, Italy
2
Department of Biomedical Sciences, University of Padova, 35121 Padova, Italy
3
Proteomics Center, University of Padova and Azienda Ospedaliera di Padova, I-35129 Padova, Italy
4
CBM scrl, Area Science Park, I-34149 Trieste, Italy
5
Department of Medical, Surgery and Health Sciences, University of Trieste, I-34149 Trieste, Italy
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2019, 8(5), 691; https://doi.org/10.3390/jcm8050691
Received: 3 April 2019 / Revised: 1 May 2019 / Accepted: 13 May 2019 / Published: 16 May 2019
(This article belongs to the Section Molecular Medicine)
  |  
PDF [1546 KB, uploaded 16 May 2019]
  |     |  

Abstract

Uterine leiomyomas are benign smooth muscle cell tumors originating from the myometrium. In this study we focus on leiomyoma and normal myometrium phosphoproteome, to identify differentially phosphorylated proteins involved in tumorigenic signaling pathways, and in anti-apoptotic processes and cell survival. We obtained paired tissue samples of seven leiomyomas and adjacent myometria and analyzed the phosphoproteome by two-dimensional gel electrophoresis (2-DE) combined with immobilized metal affinity chromatography (IMAC) and Pro-Q Diamond phosphoprotein gel stain. We used mass spectrometry for protein identification and Western blotting for 2-DE data validation. Quantities of 33 proteins enriched by the IMAC approach were significantly different in the leiomyoma if compared to the myometrium. Bioinformatic analysis revealed ten tumorigenic signaling pathways and four phosphoproteins involved in both the inhibition of apoptosis and cell survival. Our study highlights the involvement of the phosphoproteome in leiomyoma growth. Further studies are needed to understand the role of phosphorylation in leiomyoma. Our data shed light on mechanisms that still need to be ascertained, but could open the path to a new class of drugs that not only can block the growth, but could also lead to a significant reduction in tumor size. View Full-Text
Keywords: phosphoproteomics; leiomyoma; 2-DE; myometrium; mass spectrometry phosphoproteomics; leiomyoma; 2-DE; myometrium; mass spectrometry
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Ura, B.; Monasta, L.; Arrigoni, G.; Battisti, I.; Licastro, D.; Di Lorenzo, G.; Romano, F.; Aloisio, M.; Peterlunger, I.; Stabile, G.; Scrimin, F.; Ricci, G. Phosphoproteins Involved in the Inhibition of Apoptosis and in Cell Survival in the Leiomyoma. J. Clin. Med. 2019, 8, 691.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top